liu.seSearch for publications in DiVA
Endre søk
Link to record
Permanent link

Direct link
Publikasjoner (10 av 80) Visa alla publikasjoner
Haarhaus, M., Jørgensen, H. S., Bacchetta, J., Ferreira, A., Ferrari, S., Fusaro, M., . . . Evenepoel, P. (2026). Bone turnover markers in the management of CKD-associated osteoporosis-a European consensus. Nephrology, Dialysis and Transplantation, 41(7), 1357-1375
Åpne denne publikasjonen i ny fane eller vindu >>Bone turnover markers in the management of CKD-associated osteoporosis-a European consensus
Vise andre…
2026 (engelsk)Inngår i: Nephrology, Dialysis and Transplantation, ISSN 0931-0509, E-ISSN 1460-2385, Vol. 41, nr 7, s. 1357-1375Artikkel, forskningsoversikt (Fagfellevurdert) Published
Abstract [en]

Bone turnover abnormalities are common in chronic kidney disease (CKD) and contribute to bone fragility. Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) introduced the term CKD-associated osteoporosis to describe bone fragility in CKD and highlighted the role of bone turnover markers (BTM) in clinical evaluation and management of bone fragility. However, current clinical practice guidelines lack specific treatment targets for bone turnover in the setting of CKD. The aim of this consensus was to present recommendations for the use of BTM in the management of CKD-associated osteoporosis. The consensus was conducted by members of relevant working groups of the European Renal Association (ERA), International Osteoporosis Foundation (IOF), European Foundation for Clinical Chemistry and Laboratory Medicine (EFLM) and European Society of Pediatric Nephrology (ESPN). Bone-specific alkaline phosphatase and tartrate resistant acid phosphatase isoform 5b are not renally cleared and considered reliable diagnostic tools for bone evaluation in CKD-associated osteoporosis. Both have been proposed as reference BTM in CKD by a recent international consortium. Intact N-terminal telopeptide of type I collagen can also be used in CKD. The current consensus describes methodological considerations and the clinical usefulness of BTM in risk prediction, choice of therapeutic strategy, and treatment evaluation in CKD-associated osteoporosis. Specific diagnostic ranges for bone turnover abnormalities are provided. Future research should focus on the integration of these reference BTM with other diagnostic tools, establishment of concrete treatment targets, and development of treatment strategies to reach these targets.

sted, utgiver, år, opplag, sider
OXFORD UNIV PRESS, 2026
Emneord
alkaline phosphatase; bone mineral density; chronic kidney disease - mineral and bone disorder; osteoporosis; renal osteodystrophy
HSV kategori
Identifikatorer
urn:nbn:se:liu:diva-223300 (URN)10.1093/ndt/gfag033 (DOI)001744918000001 ()41700725 (PubMedID)2-s2.0-105043528239 (Scopus ID)
Tilgjengelig fra: 2026-04-27 Laget: 2026-04-27 Sist oppdatert: 2026-10-20bibliografisk kontrollert
Mackowiak, A., Bouquegneau, A., Dubois, B., Grifnee, E., Demeuse, J., Le Goff, C., . . . Cavalier, E. (2025). Changes in Bone Turnover Markers Associated With a Single Dialysis Session. Artificial Organs, 49(10), 1588-1591
Åpne denne publikasjonen i ny fane eller vindu >>Changes in Bone Turnover Markers Associated With a Single Dialysis Session
Vise andre…
2025 (engelsk)Inngår i: Artificial Organs, ISSN 0160-564X, E-ISSN 1525-1594, Vol. 49, nr 10, s. 1588-1591Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

BackgroundChronic kidney disease (CKD) is associated with disturbances in mineral and bone metabolism, increasing fracture risk, particularly in advanced stages. Bone turnover markers (BTMs) such as bone alkaline phosphatase (BALP) and tartrate-resistant acid phosphatase 5b (TRACP5b), as well as collagen-derived markers including intact form of procollagen type I amino-terminal propeptide (iPINP) and beta-cross-linked C-terminal telopeptide of type I collagen (beta-CTX-I), are recommended to assess bone turnover. Although some BTMs are considered stable and independent of renal function, their behavior during dialysis sessions remains unclear.MethodsTo assess the impact of dialysis techniques and membrane types, serum samples were collected pre- and post-dialysis. BTM concentrations were analyzed using nonparametric statistics, and the clinical relevance of the observed changes was evaluated using the least significant change (LSC) thresholds.ResultsBALP and TRACP5b showed minor fluctuations post-dialysis, with changes remaining below their clinical significance thresholds. iPINP also showed limited variability. In contrast, beta-CTX-I decreased significantly after hemodialysis, especially using high-permeability membranes, with changes exceeding the LSC threshold.ConclusionThese findings suggest that BALP, TRACP5b, and PINP demonstrate robustness as BTMs in CKD patients undergoing dialysis. However, beta-CTX-I is markedly affected by dialysis parameters and should be interpreted cautiously in this context.

sted, utgiver, år, opplag, sider
WILEY, 2025
Emneord
bone turnover markers; dialysis membrane; hemodiafiltration; hemodialysis
HSV kategori
Identifikatorer
urn:nbn:se:liu:diva-216765 (URN)10.1111/aor.15053 (DOI)001520316200001 ()40590834 (PubMedID)2-s2.0-105009824154 (Scopus ID)
Tilgjengelig fra: 2025-08-25 Laget: 2025-08-25 Sist oppdatert: 2026-04-21bibliografisk kontrollert
Atanasova, D., Mirgorodskaya, E., Moparthi, L., Koch, S., Haarhaus, M., Narisawa, S., . . . Magnusson, P. (2024). Glycoproteomic profile of human tissue-nonspecific alkaline phosphatase expressed in osteoblasts. JBMR Plus, 8(2), Article ID ziae006.
Åpne denne publikasjonen i ny fane eller vindu >>Glycoproteomic profile of human tissue-nonspecific alkaline phosphatase expressed in osteoblasts
Vise andre…
2024 (engelsk)Inngår i: JBMR Plus, E-ISSN 2473-4039, Vol. 8, nr 2, artikkel-id ziae006Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Tissue-nonspecific alkaline phosphatase (TNALP) is a glycoprotein expressed by osteoblasts that promotes bone mineralization. TNALP catalyzes the hydrolysis of the mineralization inhibitor inorganic pyrophosphate and ATP to provide inorganic phosphate, thus controlling the inorganic pyrophosphate/inorganic phosphate ratio to enable the growth of hydroxyapatite crystals. N-linked glycosylation of TNALP is essential for protein stability and enzymatic activity and is responsible for the presence of different bone isoforms of TNALP associated with functional and clinical differences. The site-specific glycosylation profiles of TNALP are, however, elusive. TNALP has 5 potential N-glycosylation sites located at the asparagine (N) residues 140, 230, 271, 303, and 430. The objective of this study was to reveal the presence and structure of site-specific glycosylation in TNALP expressed in osteoblasts. Calvarial osteoblasts derived from Alpl+/− expressing SV40 Large T antigen were transfected with soluble epitope-tagged human TNALP. Purified TNALP was analyzed with a lectin microarray, matrix-assisted laser desorption/ionization-time of flight mass spectrometry, and liquid chromatography with tandem mass spectrometry. The results showed that all sites (n = 5) were fully occupied predominantly with complex-type N-glycans. High abundance of galactosylated biantennary N-glycans with various degrees of sialylation was observed on all sites, as well as glycans with no terminal galactose and sialic acid. Furthermore, all sites had core fucosylation except site N271. Modelling of TNALP, with the protein structure prediction software ColabFold, showed possible steric hindrance by the adjacent side chain of W270, which could explain the absence of core fucosylation at N271. These novel findings provide evidence for N-linked glycosylation on all 5 sites of TNALP, as well as core fucosylation on 4 out of 5 sites. We anticipate that this new knowledge can aid in the development of functional and clinical assays specific for the TNALP bone isoforms.

sted, utgiver, år, opplag, sider
Oxford University Press, 2024
Emneord
alkaline phosphatase, biomineralization, N-linked glycosylation, glycoprotein, bone formation
HSV kategori
Identifikatorer
urn:nbn:se:liu:diva-201385 (URN)10.1093/jbmrpl/ziae006 (DOI)001203141400014 ()38505526 (PubMedID)2-s2.0-85193616756 (Scopus ID)
Forskningsfinansiär
Swedish Research CouncilSwedish Cancer SocietyKnut and Alice Wallenberg Foundation
Merknad

Funding Agencies|Swedish Research Council; BioMS - Swedish Research Council

Tilgjengelig fra: 2024-03-06 Laget: 2024-03-06 Sist oppdatert: 2026-05-08bibliografisk kontrollert
Jaiswal, R., Johansson, H., Axelsson, K. F., Magnusson, P., Harvey, N. C., Vandenput, L., . . . Lorentzon, M. (2023). Hemoglobin Levels Improve Fracture Risk Prediction in Addition to FRAX Clinical Risk Factors and Bone Mineral Density. Journal of Clinical Endocrinology and Metabolism, 108(12), e1479-e1488
Åpne denne publikasjonen i ny fane eller vindu >>Hemoglobin Levels Improve Fracture Risk Prediction in Addition to FRAX Clinical Risk Factors and Bone Mineral Density
Vise andre…
2023 (engelsk)Inngår i: Journal of Clinical Endocrinology and Metabolism, ISSN 0021-972X, E-ISSN 1945-7197, Vol. 108, nr 12, s. e1479-e1488Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

ontext: Anemia and decreasing levels of hemoglobin (Hb) have previously been linked to increased fracture risk, but the added value to FRAX, the most utilized fracture prediction tool worldwide, is unknown.

Objective: To investigate the association between anemia, Hb levels, bone microstructure, and risk of incident fracture and to evaluate whether Hb levels improve fracture risk prediction in addition to FRAX clinical risk factors (CRFs).

Methods: A total of 2778 community-dwelling women, aged 75-80 years, and part of a prospective population-based cohort study in Sweden were included. At baseline, information on anthropometrics, CRFs, and falls was gathered, blood samples were collected, and skeletal characteristics were investigated using dual-energy x-ray absorptiometry and high-resolution peripheral quantitative computed tomography. At the end of follow-up, incident fractures were retrieved from a regional x-ray archive.

Results: The median follow-up time was 6.4 years. Low Hb was associated with worse total hip and femoral neck bone mineral density (BMD), and lower tibia cortical and total volumetric BMD, and anemia was associated with increased risk of major osteoporotic fracture (MOF; hazard ratio 2.04; 95% CI 1.58-2.64). Similar results were obtained for hip fracture and any fracture, also when adjusting for CRFs. The ratio between 10-year fracture probabilities of MOF assessed in models with Hb levels included and not included ranged from 1.2 to 0.7 at the 10th and 90th percentile of Hb, respectively.

Conclusion: Anemia and decreasing levels of Hb are associated with lower cortical BMD and incident fracture in older women. Considering Hb levels may improve the clinical evaluation of patients with osteoporosis and the assessment of fracture risk.

sted, utgiver, år, opplag, sider
Endocrine Society, 2023
Emneord
anemia; fracture risk; fracture risk assessment; hemoglobin level; older women
HSV kategori
Identifikatorer
urn:nbn:se:liu:diva-201785 (URN)10.1210/clinem/dgad399 (DOI)001162731800001 ()37406247 (PubMedID)
Forskningsfinansiär
Swedish Research Council
Merknad

Funding: Swedish Research Council; IngaBritt and Arne Lundberg Foundation; ALF/LUA grant from the Sahlgrenska University Hospitals Research Foundations

Tilgjengelig fra: 2024-03-21 Laget: 2024-03-21 Sist oppdatert: 2025-02-04
Skogastierna, C., Elfvin, A., Hansson, S., Magnusson, P. & Swolin-Eide, D. (2022). Impaired renal clearance among Swedish adolescents born preterm. Acta Paediatrica, 111(9), 1722-1728
Åpne denne publikasjonen i ny fane eller vindu >>Impaired renal clearance among Swedish adolescents born preterm
Vise andre…
2022 (engelsk)Inngår i: Acta Paediatrica, ISSN 0803-5253, E-ISSN 1651-2227, Vol. 111, nr 9, s. 1722-1728Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Aim To determine whether adolescents born before 28 gestational weeks have an increased risk for renal impairment. Methods Swedish infants, born before 28 gestational weeks in 2001 and 2002, were identified from a local register. A total of 16 children, 12 females and 4 males, were examined at 16-17 years of age with Cr-51-EDTA clearance. A comparison group (n = 26) was used. Results Most study participants (n = 13) had normal blood pressure; one individual had hypertension stage 1. All study participants had results within the reference interval for ionised calcium, parathyroid hormone, intact fibroblast growth factor-23 and for urinary albumin-to-creatinine ratio. Four out of 16 participants (25%) had a Cr-51-EDTA clearance less than 90 ml/min/1.73 m(2), indicating a reduced kidney function. Measured Cr-51-EDTA clearance values were significantly lower in the study group than in the comparison group (p = 0.0012). Five study participants (31%) were referred for further investigations. Conclusion Swedish children born before 28 gestational weeks have an increased risk of renal impairment later in life, suggesting that the kidney function in these individuals should be assessed, at least once, during adolescence.

sted, utgiver, år, opplag, sider
Wiley, 2022
Emneord
adolescent; kidney function tests; extremely preterm infant; neonatology; nephrology
HSV kategori
Identifikatorer
urn:nbn:se:liu:diva-185270 (URN)10.1111/apa.16379 (DOI)000792111300001 ()35490381 (PubMedID)
Merknad

Funding Agencies|Swedish government; county councils [ALFGBG-716831, ALFGBG-678871]; ALF grants from Region Ostergotland; Agrenska research foundation

Tilgjengelig fra: 2022-05-25 Laget: 2022-05-25 Sist oppdatert: 2023-03-10bibliografisk kontrollert
Svedlund, A., Tubic, B., Elfvin, A., Magnusson, P. & Swolin-Eide, D. (2022). The Significance of the FTO Gene for Weight and Body Composition in Swedish Women With Severe Anorexia Nervosa During Intensive Nutrition Therapy. Journal of the American Nutrition Association, 41(6), 594-599
Åpne denne publikasjonen i ny fane eller vindu >>The Significance of the FTO Gene for Weight and Body Composition in Swedish Women With Severe Anorexia Nervosa During Intensive Nutrition Therapy
Vise andre…
2022 (engelsk)Inngår i: Journal of the American Nutrition Association, ISSN 2769-7061, Vol. 41, nr 6, s. 594-599Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Objective: The aim of this prospective study was to investigate the potential influence of the fat mass and obesity-associated gene (FTO), SNP rs9939609, on body mass index (BMI) and body composition in women with anorexia nervosa (AN) undergoing intensive nutrition therapy. Method: Twenty-five female patients with AN (20.1 +/- 2.3 years; BMI, 15.5 +/- 0.9 kg/m(2)) were included for 12 weeks of treatment with a high-energy diet. FTO was genotyped and body composition parameters were assessed by dual-energy X-ray absorptiometry and peripheral quantitative computed tomography at baseline and after 12 weeks. Results: The distribution of the different FTO genotypes were as follows: AA, 24%; TA, 48%; and TT, 28%. Patients gained a median of 9.8 kg (range, 5.5-17.0 kg) and BMI increased to 19.0 +/- 0.9 kg/m(2). The increase in BMI, fat mass, and the quotient fat/muscle area was significant for the TT and TA genotype groups. Total lean mass was stable in all genotype groups. We could not demonstrate any difference among the 3 FTO genotypes related to the increases in BMI during nutrition therapy when the additive, dominant, and recessive models of inheritance were applied. Conclusions: Irrespective of the FTO genotype, there was no difference in weight response during nutrition therapy. Hence, in this small study there was limited support for individualized nutrition therapy for AN based on FTO genotype.

sted, utgiver, år, opplag, sider
Routledge; Taylor & Francis, 2022
Emneord
Eating disorder; fat mass and obesity-associated gene; body mass index; nutrition therapy
HSV kategori
Identifikatorer
urn:nbn:se:liu:diva-178548 (URN)10.1080/07315724.2021.1945979 (DOI)000675083900001 ()34283000 (PubMedID)2-s2.0-85139124818 (Scopus ID)
Tilgjengelig fra: 2021-08-26 Laget: 2021-08-26 Sist oppdatert: 2025-11-06bibliografisk kontrollert
Larsson, B. A., Johansson, L., Johansson, H., Axelsson, K. F., Harvey, N., Vandenput, L., . . . Lorentzon, M. (2021). The timed up and go test predicts fracture risk in older women independently of clinical risk factors and bone mineral density. Osteoporosis International, 32, 75-84
Åpne denne publikasjonen i ny fane eller vindu >>The timed up and go test predicts fracture risk in older women independently of clinical risk factors and bone mineral density
Vise andre…
2021 (engelsk)Inngår i: Osteoporosis International, ISSN 0937-941X, E-ISSN 1433-2965, Vol. 32, s. 75-84Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

The timed up and go (TUG) test measures physical performance and predicts falls in the elderly. In older women, TUG time predicts the risk of major osteoporotic fracture and hip fracture independently of clinical risk factors and bone mineral density, and has a substantial impact on fracture probabilities. Introduction The timed up and go (TUG) test measures physical performance and predicts falls in the elderly. A slow TUG has been associated with an increased fracture risk, but it is unclear whether the association is independent of clinical risk factors and bone mineral density (BMD). The aim of this study was to investigate if TUG time was associated with fracture risk independently of clinical risk factors and BMD and to determine its impact on fracture probabilities in older women. Methods A standardized questionnaire was used to assess information regarding clinical risk factors in the large population-based SUPERB study of 3028 older women (75-80 years). At baseline, the TUG test was performed and BMD measured with DXA. The association between TUG time and the risk of hip fracture and major osteoporotic fracture (MOF) was examined using an extension of Poisson regression. Results Fracture incidence increased steeply with increasing TUG time up to 12 s and subsequently started to level off. A slow TUG time was therefore defined as TUG > 12 s, a cutoff level then used in Cox models to study the association between slow TUG and fracture risk. A slow TUG time was associated with an increased risk of fracture (MOF 2.39 [1.80-3.18] and hip fracture 2.96 [1.62-5.40]). These associations were slightly attenuated but remained significant after adjustment for clinical risk factors and femoral neck BMD. Depending on BMD, the 4-year fracture probability of MOF increased by a factor of 1.5-1.9 in a 75-year-old woman with slow TUG (> 12 s). Conclusion The TUG time predicts the risk of MOF and hip fracture independently of clinical risk factors and BMD and has a substantial impact on fracture probabilities, indicating that inclusion of the TUG test in patient evaluation should be considered in order to improve fracture prediction in older women.

sted, utgiver, år, opplag, sider
SPRINGER LONDON LTD, 2021
Emneord
Clinical risk factors and bone mineral density; Fracture risk; The timed up and go test
HSV kategori
Identifikatorer
urn:nbn:se:liu:diva-171195 (URN)10.1007/s00198-020-05681-w (DOI)000582295900001 ()33089354 (PubMedID)
Merknad

Funding Agencies|University of Gothenburg

Tilgjengelig fra: 2020-11-13 Laget: 2020-11-13 Sist oppdatert: 2022-05-25
Johansson, L., Sundh, D., Magnusson, P., Rukmangatharajan, K., Mellström, D., Nilsson, A. G. & Lorentzon, M. (2020). Because prevalent vertebral fracture (VF) is a strong predictor of future fractures, they are important to identify in clinical practice as osteoporosis medications are effective and can be used to reduce fracture risk in postmenopausal women with VF. Lateral spine imaging (LSI) with dual-energy X-ray absorptiometry (DXA) can be used to diagnose VFs accurately but is not widespread in clinical practice. The prognostic value of grade 1 (20% to 25% compression) VFs diagnosed by LSI with DXA has been insufficiently studied. The aim of this study was to determine if grade 1 VF is associated with incident fracture in older women. Sahlgrenska University Hospital Prospective Evaluation of Risk of Bone Fractures (SUPERB) is a population-based study of 3028 older women from Gothenburg, Sweden. Included women were 75 to 80 years of age at baseline, answered questionnaires, and were scanned with DXA (Discovery A, Hologic, Waltham, MA, USA). LSI was used to diagnose VFs, which were classified using the Genant semiquantitative method. Cox regression models were used to estimate the association between VFs at baseline and X-ray-verified incident fractures, with adjustment for confounders. Women with a grade 1 VF (n= 264) or a grade 2-3 VF (n= 349) were compared with women without any fracture (n= 1482). During 3.6 years (median, interquartile range [IQR] 1.5 years) of follow-up, 260 women had any incident fracture and 213 a major osteoporotic fracture (MOF). Women with only grade 1 VF had increased risk of any fracture (hazard ratio [HR] = 1.67; 95% confidence interval [CI] 1.18-2.36) and MOF (HR = 1.86; 95% CI 1.28-2.72). For MOF, this association remained after adjustment for clinical risk factors and femoral neck bone mineral density (BMD). In conclusion, grade 1 VFs were associated with incident MOF, also after adjustment for clinical risk factors and BMD, indicating that all VF identified by DXA should be considered in the evaluation of fracture risk in older women. (c) 2020 The Authors.Journal of Bone and Mineral Researchpublished by American Society for Bone and Mineral Research.. Journal of Bone and Mineral Research, 35(10), 1942-1951
Åpne denne publikasjonen i ny fane eller vindu >>Because prevalent vertebral fracture (VF) is a strong predictor of future fractures, they are important to identify in clinical practice as osteoporosis medications are effective and can be used to reduce fracture risk in postmenopausal women with VF. Lateral spine imaging (LSI) with dual-energy X-ray absorptiometry (DXA) can be used to diagnose VFs accurately but is not widespread in clinical practice. The prognostic value of grade 1 (20% to 25% compression) VFs diagnosed by LSI with DXA has been insufficiently studied. The aim of this study was to determine if grade 1 VF is associated with incident fracture in older women. Sahlgrenska University Hospital Prospective Evaluation of Risk of Bone Fractures (SUPERB) is a population-based study of 3028 older women from Gothenburg, Sweden. Included women were 75 to 80 years of age at baseline, answered questionnaires, and were scanned with DXA (Discovery A, Hologic, Waltham, MA, USA). LSI was used to diagnose VFs, which were classified using the Genant semiquantitative method. Cox regression models were used to estimate the association between VFs at baseline and X-ray-verified incident fractures, with adjustment for confounders. Women with a grade 1 VF (n= 264) or a grade 2-3 VF (n= 349) were compared with women without any fracture (n= 1482). During 3.6 years (median, interquartile range [IQR] 1.5 years) of follow-up, 260 women had any incident fracture and 213 a major osteoporotic fracture (MOF). Women with only grade 1 VF had increased risk of any fracture (hazard ratio [HR] = 1.67; 95% confidence interval [CI] 1.18-2.36) and MOF (HR = 1.86; 95% CI 1.28-2.72). For MOF, this association remained after adjustment for clinical risk factors and femoral neck bone mineral density (BMD). In conclusion, grade 1 VFs were associated with incident MOF, also after adjustment for clinical risk factors and BMD, indicating that all VF identified by DXA should be considered in the evaluation of fracture risk in older women. (c) 2020 The Authors.Journal of Bone and Mineral Researchpublished by American Society for Bone and Mineral Research.
Vise andre…
2020 (engelsk)Inngår i: Journal of Bone and Mineral Research, ISSN 0884-0431, E-ISSN 1523-4681, Vol. 35, nr 10, s. 1942-1951Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Because prevalent vertebral fracture (VF) is a strong predictor of future fractures, they are important to identify in clinical practice as osteoporosis medications are effective and can be used to reduce fracture risk in postmenopausal women with VF. Lateral spine imaging (LSI) with dual-energy X-ray absorptiometry (DXA) can be used to diagnose VFs accurately but is not widespread in clinical practice. The prognostic value of grade 1 (20% to 25% compression) VFs diagnosed by LSI with DXA has been insufficiently studied. The aim of this study was to determine if grade 1 VF is associated with incident fracture in older women. Sahlgrenska University Hospital Prospective Evaluation of Risk of Bone Fractures (SUPERB) is a population-based study of 3028 older women from Gothenburg, Sweden. Included women were 75 to 80 years of age at baseline, answered questionnaires, and were scanned with DXA (Discovery A, Hologic, Waltham, MA, USA). LSI was used to diagnose VFs, which were classified using the Genant semiquantitative method. Cox regression models were used to estimate the association between VFs at baseline and X-ray-verified incident fractures, with adjustment for confounders. Women with a grade 1 VF (n = 264) or a grade 2-3 VF (n = 349) were compared with women without any fracture (n = 1482). During 3.6 years (median, interquartile range [IQR] 1.5 years) of follow-up, 260 women had any incident fracture and 213 a major osteoporotic fracture (MOF). Women with only grade 1 VF had increased risk of any fracture (hazard ratio [HR] = 1.67; 95% confidence interval [CI] 1.18-2.36) and MOF (HR = 1.86; 95% CI 1.28-2.72). For MOF, this association remained after adjustment for clinical risk factors and femoral neck bone mineral density (BMD). In conclusion, grade 1 VFs were associated with incident MOF, also after adjustment for clinical risk factors and BMD, indicating that all VF identified by DXA should be considered in the evaluation of fracture risk in older women. © 2020 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research..

sted, utgiver, år, opplag, sider
Wiley-Blackwell, 2020
Emneord
DXA, INCIDENT FRACTURE, MILD VERTEBRAL FRACTURE, OLDER WOMEN, VERTEBRAL FRACTURE ASSESSMENT
HSV kategori
Identifikatorer
urn:nbn:se:liu:diva-173357 (URN)10.1002/jbmr.4108 (DOI)000545503600001 ()32539162 (PubMedID)2-s2.0-85087566356 (Scopus ID)
Merknad

Funding agencies: The Swedish Research Council (VR), the ALF/LUA grant from the Sahlgrenska University Hospital, the Swedish Society of Medicine, the Gothenburg Society of Medicine, the King Gustaf V’s and Queen Victoria’s Freemason Foundation, and the Inga-Britt and Arne Lundberg Foundation

Tilgjengelig fra: 2021-02-17 Laget: 2021-02-17 Sist oppdatert: 2021-03-22bibliografisk kontrollert
Swolin-Eide, D. & Magnusson, P. (2020). Does Whole-Body Vibration Treatment Make Childrens Bones Stronger?. CURRENT OSTEOPOROSIS REPORTS, 18, 471-479
Åpne denne publikasjonen i ny fane eller vindu >>Does Whole-Body Vibration Treatment Make Childrens Bones Stronger?
2020 (engelsk)Inngår i: CURRENT OSTEOPOROSIS REPORTS, ISSN 1544-1873, Vol. 18, s. 471-479Artikkel, forskningsoversikt (Fagfellevurdert) Published
Abstract [en]

Purpose of Review To summarize the last 10 years of literature regarding the effects of whole-body vibration (WBV) on bone in children, and if WBV results in increased bone acquisition. Recent Findings WBV intervention appears to be a safe intervention with beneficial effects on bone mass in some diseases and syndromes, but there is still low evidence for WBV in clinical practice. The positive effects on muscle strength, balance, and walking speed are more conclusive. One of the takeaways of this review is that well-trained individuals may not further improve bone mass with WBV; thus, interventions are more beneficial in pediatric individuals with Down syndrome or severe motor disabilities with low bone mass and reduced activity levels. WBV appears to be a safe non-pharmacological anabolic approach to increase bone mass in some pediatric populations; however, longer (> 6 months) and larger prospective studies are needed to elucidate the efficacy of WBV on bone health in young individuals.

sted, utgiver, år, opplag, sider
SPRINGER, 2020
Emneord
Bone mineral density; Pediatric; Mechanical oscillation; Rehabilitation; Physical activity; Skeleton
HSV kategori
Identifikatorer
urn:nbn:se:liu:diva-168557 (URN)10.1007/s11914-020-00608-0 (DOI)000551087700001 ()32696294 (PubMedID)2-s2.0-85088301295 (Scopus ID)
Merknad

Funding Agencies|University of Gothenburg; Swedish government [ALFGBG-716831, 678871]; Swedish county councils, the ALF-agreement [ALFGBG-716831, 678871]; ALF grants from Region Ostergotland

Tilgjengelig fra: 2020-08-28 Laget: 2020-08-28 Sist oppdatert: 2025-08-21bibliografisk kontrollert
Haarhaus, M., Gilham, D., Kulikowski, E., Magnusson, P. & Kalantar-Zadeh, K. (2020). Pharmacologic epigenetic modulators of alkaline phosphatase in chronic kidney disease. Current opinion in nephrology and hypertension, 29(1), 4-15
Åpne denne publikasjonen i ny fane eller vindu >>Pharmacologic epigenetic modulators of alkaline phosphatase in chronic kidney disease
Vise andre…
2020 (engelsk)Inngår i: Current opinion in nephrology and hypertension, ISSN 1062-4821, E-ISSN 1473-6543, Vol. 29, nr 1, s. 4-15Artikkel, forskningsoversikt (Fagfellevurdert) Published
Abstract [en]

PURPOSE OF REVIEW: In chronic kidney disease (CKD), disturbance of several metabolic regulatory mechanisms cause premature ageing, accelerated cardiovascular disease (CVD), and mortality. Single-target interventions have repeatedly failed to improve the prognosis for CKD patients. Epigenetic interventions have the potential to modulate several pathogenetic processes simultaneously. Alkaline phosphatase (ALP) is a robust predictor of CVD and all-cause mortality and implicated in pathogenic processes associated with CVD in CKD.

RECENT FINDINGS: In experimental studies, epigenetic modulation of ALP by microRNAs or bromodomain and extraterminal (BET) protein inhibition has shown promising results for the treatment of CVD and other chronic metabolic diseases. The BET inhibitor apabetalone is currently being evaluated for cardiovascular risk reduction in a phase III clinical study in high-risk CVD patients, including patients with CKD (ClinicalTrials.gov Identifier: NCT02586155). Phase II studies demonstrate an ALP-lowering potential of apabetalone, which was associated with improved cardiovascular and renal outcomes.

SUMMARY: ALP is a predictor of CVD and mortality in CKD. Epigenetic modulation of ALP has the potential to affect several pathogenetic processes in CKD and thereby improve cardiovascular outcome.

sted, utgiver, år, opplag, sider
Lippincott Williams & Wilkins, 2020
HSV kategori
Identifikatorer
urn:nbn:se:liu:diva-173358 (URN)10.1097/MNH.0000000000000570 (DOI)000619275000002 ()31725015 (PubMedID)2-s2.0-85076065609 (Scopus ID)
Merknad

Funding agencies: P.M. is supported by ALF grants Region Ostergotland, Sweden. K.K.-Z. is supported by the NIDDK grants R01DK095668 and K24-DK091419 as well as philanthropic grants from Mr Harold Simmons, Mr Louis Chang, Dr Joseph Lee and AVEO.

Tilgjengelig fra: 2021-02-17 Laget: 2021-02-17 Sist oppdatert: 2025-02-18bibliografisk kontrollert
Organisasjoner
Identifikatorer
ORCID-id: ORCID iD iconorcid.org/0000-0002-2123-7838